samedan logo
 
 
spacer
home > epc > spring 2018 > early beginnings
PUBLICATIONS
European Pharmaceutical Contractor

Early Beginnings

Moving a promising drug candidate from the laboratory to first-in-human (FIH) trials is a complex, multistage challenge. Coordinating the formulation development steps, manufacturing, and logistics involved requires careful management and planning.

Integrating the process in collaboration with expert vendors offers drug developers an efficient, cost-effective pathway to success in early phase development. Furthermore, experienced contractors can help drug companies avoid the early phase pitfalls that can see projects fail at a later stage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

spacer
Dr Torkel Gren is General Manager at Recipharm Pharmaceutical Development. Torkel holds degrees in pharmacy and business administration, as well a PhD in Pharmaceutics from Uppsala University, Sweden. He has worked in the pharma industry since 1988 and has held a number of scientist and manager positions in Europe and the US. Torkel was lead formulator and co-inventor of Detrol OD/Detrusitol SR. He is a member of the board of the Swedish Pharmaceutical Society.

Anders Millerhovf is CEO at CTC Clinical Trial Consultants. He holds a degree in medical biology from Linköping University, Sweden. Anders has worked in the life sciences industry since 2002 and has been focused on Phase 0-2a projects in various management and director positions. He has been a partner at CTC since 2012.
spacer
Dr Torkel Gren
spacer
spacer
spacer
Anders Millerhovf
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Datwyler celebrates official opening of its new production plant with First Line standard in Middletown, Del

• The new facility in Middletown, Del., is Datwyler’s third facility with First Line standard which will be catering to the markets in North and South America • Approximately 120 jobs will be created, with the majority staffed from the local community • With the Middletown facility, Datwyler will be able to increase its global First Line production by 50 percent by 2020 • First Line is specially designed to manufacture biotech and pharmaceutical elastomer components in a fully integrated good manufacturing practice (GMP) environment
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement